Digital health startups raised $7.4 billion during the first half of the year, up from $6.4 billion during the first half of 2025, according to data released this week by
Answers at the Speed of Thought: Healthcare Analytics in the Era of Agentic AI
Claude Shannon, the father of information theory, famously defined information as “the resolution of uncertainty.” In healthcare analytics, our uncertainty is high not because we lack data (in fact, we
How Fairview Health Services Turned Around a $315M Loss
In just two years, Minnesota-based Fairview Health Services turned a $315 million annual loss into a nearly $600 million turnaround. Fairview lost money every year from 2019 to 2023, with
Coalition Urges Policymakers to Reject No Surprises Act Enforcement Bill
The Coalition Against Surprise Medical Billing launched a “six-figure” ad campaign on Monday that calls on policymakers to reject the No Surprises Act Enforcement Act, which the organization argues will
Why the Next Era of Sleep Medicine Depends on Better Diagnostics
For decades, the diagnostic pathway for a patient with suspected obstructive sleep apnea (OSA) has followed a predictable sequence. The patient gets tested in a sleep lab overnight, a technician
Kaiser Nurses Protest CEO’s AHA Appearance Over AI Concerns
On Monday, Kaiser Permanente CEO Greg Adams took the stage at the American Hospital Association‘s Leadership Summit in Denver to make the case that his organization is cracking the code
GSK Eyes FDA Filing After Immunotherapy Succeeds in Key Rectal Cancer Study
GSK has results from a pivotal clinical trial showing rectal cancer patients treated with its drug avoided the need for the much more invasive surgical removal of their tumors. The
Obesity Is Tied to Hundreds of Gene Variants — Why Are We Only Talking About Two?
Glucagon-like peptide-1 (GLP-1) receptor agonist drugs are revolutionizing care for people with obesity, which affects more than 40% of U.S. adults, offering levels of weight loss that were previously difficult
Former Mayo Clinic Leader Sues System Over Alleged AI Cover-Up: 6 Things to Know
Traci Tamiko Eto said she spent a year and a half trying to warn Mayo Clinic that its AI strategy was cutting corners on patient privacy and safety. Now she’s
AstraZeneca Turns to China for Molecule That Might Top New Merck COPD Drug
AstraZeneca’s newest addition to its respiratory pipeline is an inhalable medication that could rival a Merck drug approved for treating chronic obstructive pulmonary disease (COPD). The drug, TQC721, comes from









